Surgical Safety Technologies Rebrands as Aimbient, Broadens Ambient AI Platform
Rebranding signifies a shift towards continuous intelligence before, during, and after procedures to support clinical workflows
Read More
Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging
Quibim’s technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startup’s customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.
Uncertainty Follows Senate’s Rejection of Competing Healthcare Proposals
If Congress does not act, many Marketplace enrollees will face significantly higher net premiums in 2026, expert cautions
Innovation Fatigue is Rampant: What’s the Rx to Fix It?
It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.
A Teen’s Murder, Mold in the Walls: Unfulfilled Promises Haunt Public Housing
SAVANNAH, Ga. — Blocks from where tourists stroll along the cobblestoned riverfront in this racially divided city, Detraya Gilliard made her way down the dark, ruptured sidewalks of Yamacraw Village, looking for her missing 15-year-old daughter. Like most other people living in one of the nation’s oldest public housing projects, Gilliard endured the boarded-up buildings…
New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
Millions of people who apply for Medicaid in the coming years will have to prove they’ve been working, going to school, or volunteering for at least a month before they can gain or retain health insurance through the government program. But Republican lawmakers in some states think the new rules — part of the GOP’s…
FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in Decades
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant’s $14 billion acquisition of Karuna Therapeutics. The post FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in…
GSK Gets FDA Approval for New Severe Asthma Drug With a Dosing Advantage
GSK’s Exdensur requires just two injections a year to treat severe asthma. Less frequent injections give this new biologic medicine a dosing edge over one of GSK’s own blockbuster respiratory products as well as severe asthma drugs from companies such as AstraZeneca, Sanofi, and Amgen. The post GSK Gets FDA Approval for New Severe Asthma…
Making Exercise a Standard in Cancer Survivorship Care
We know that exercise is medicine. The science is clear, the mechanisms are known, and the tools are available to deliver it safely. To make all that mean something for patients, cancer care must evolve to include movement as a standard element of every stage of the journey, not as a wellness option, but as…
How Expanded Reimbursement for Coronary CTA (CCTA) Could Improve Cardiovascular Outcomes
With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows. The post How Expanded Reimbursement for Coronary CTA…